Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire

Rui Usui; Shogo Kanamori; Maki Aomori; Setsuko Watabe

doi:10.4081/jphia.2022.1748

Authors

Rui Usui
usuir@yokohama-cu.ac.jp
Department of Nursing, Graduate School of Medicine, The Yokohama City University, Yokohama, Kanagawa, Japan; Department of Critical and Invasive-Palliative Care Nursing, Graduate School of Health Care Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan. https://orcid.org/0000-0002-2236-162X
Shogo Kanamori Department of Community and Global Health, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Maki Aomori Department of Nursing, Graduate School of Medicine, The Yokohama City University, Yokohama, Kanagawa, Japan.
Setsuko Watabe Department of Nursing, Graduate School of Medicine, The Yokohama City University, Yokohama, Kanagawa, Japan.

Background: Although COVID-19 has spread in Côte d’Ivoire, there is no report that summarizes the comorbidities of COVID-19 death cases.
Objective: To verify the types and prevalence of commodities associated with recorded COVID-19 deaths compared with the general adult population in Côte d’Ivoire. Methods: Data on the comorbidities of COVID-19 deaths and the country’s disease structure were collected from official government reports and WHO’s reports.
Results: Among 67 patients studied, the biggest age group was 60- 69 years old with 23 people (34%). Fifty-four patients (81%) had non-communicable diseases (NCDs) as comorbidities. The prevalence ratio between COVID-19 deaths and general adult population was 8.96 [95% Confidence Interval: 6.86-11.68] for diabetes, 1.74 [1.27-2.37] for hypertension, and 2.16 [1.32-3.51] for obesity.
Conclusions: To reduce the risk of death from COVID-19 in Côte d’Ivoire, focused infection prevention measures for elderly and diabetic patients are needed.

1. Wortham JM, Lee JT, Althomsons S, Latash J, Davidson A, Guerra K, et al. Characteristics of Persons Who Died with COVID-19 - United States, February 12-May 18, 2020. Morbidity and Mortality Weekly Report 2020;69(28):923-9.
2. Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging. 2020;12(7):6049-57.
3. Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ (Clinical research ed). 2020;368:m1198.
4. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. The Journal of infection. 2020;81(2):e16-e25.
5. Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430-6.
6. Mabéha J. Côte d’Ivoire : Covid-19, voici le nombre de lits pour les hospital 2020 [cited 2020 Nov 16]. Available from: https://apr-news.fr/fr/actualites/cote-divoire-covid-19-voici-le-nombre-de-lits-pour-les-hospitalisations.
7. Ministère de la Santé et l'Hygiène Publique Côte d'Ivoire. Point de la situation de la COVID-19 au 15/11/2020 2020 [cited 2020 Nov 16]. Available from: http://www.sante.gouv.ci/welcome/actualites/881.
8. Ministère de la Santé et l'Hygiène Publique Côte d'Ivoire, World Health Organization (WHO). Réponse à l’épidémie due à la maladie à coronavirus (COVID-19)-Rapport de situation nº188 du 21 Oct 2020-. 2020.
9. Ministère de la Santé et l'Hygiène Publique Côte d'Ivoire. Ministère de la Santé et l'Hygiène Publique 2020 [cited 2020 Nov 16]. Available from: http://www.sante.gouv.ci/?fbclid=IwAR2J8k1Tl4uuj3f_odyySjHZJKd_KsfnrB7ym4mXt-mOD0XBUpwNekJOFts.
10. World Health Organization (WHO). The global health observatory -Explore a world of health data- 2020 [cited 2020 Nov 16]. Available from: https://www.who.int/data/gho/data/indicators.
11. Institiut National de la Statistique Republique de Côte d'ivoire. Recensement Général de la Population et de l’Habitat -2014 Résultats Globaux. 2015.
12. Anjorin AA, Abioye AI, Asowata OE, Soipe A, Kazeem MI, Adesanya IO, et al. Comorbidities and the COVID-19 pandemic dynamics in Africa. Tropical medicine & international health : TM & IH. 2020.
13. Team TNCPERE. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi. 2020;41(2):145.
14. Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, et al. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. Journal of medical virology. 2020.
15. Palmieri L, Andrianou X, Bella A, Bellino S, Boros S, Canevelli M. Characteristics of COVID-19 patients dying in Italy report based on available data on March 20th, 2020. Istituto Superiore di Sanità. 2020.
16. Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell metabolism. 2020;31(6):1068-77.e3.
17. Portail Officiel du gouvernement de Côte d’Ivoire. Traitement du Diabète :100 millions de Fcfa de matériels remis à sept unités de prise en charge 2019 [cited 2020 Nov 16]. Available from: http://www.gouv.ci/_actualite-article.php?recordID=9808.

Usui, R., Kanamori, S., Aomori, M., & Watabe, S. (2022). Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire. Journal of Public Health in Africa, 13(3). https://doi.org/10.4081/jphia.2022.1748